Literature DB >> 24101018

Location of lymph node involvement in patients with esophageal adenocarcinoma predicts survival.

Aaldert K Talsma1, Chin-Ann J Ong, Xinxue Liu, Pieter van Hagen, Jan J B Van Lanschot, Huug W Tilanus, Richard H Hardwick, Nicholas R Carroll, Manon C W Spaander, Rebecca C Fitzgerald, Bas P L Wijnhoven.   

Abstract

BACKGROUND: The location of positive lymph nodes has been abandoned in the seventh classification of the TNM staging system for esophageal adenocarcinoma. The present study evaluates whether distribution of involved nodes relative to the diaphragm in addition to TNM 7 further refines prediction.
METHODS: Pathology reports of patients who underwent esophagectomy between 2000 and 2008 for adenocarcinoma of the esophagus were reviewed and staging was performed according to the seventh UICC-AJCC staging system. In addition, lymph node involvement of nodal stations above and below the diaphragm was investigated by endoscopic ultrasonography (EUS) in a separate cohort of patients who were scheduled for esophagectomy between 2008 and 2009 at two institutions. Survival was calculated by the Kaplan-Meier method, and multivariate analysis was performed with a Cox regression model.
RESULTS: Some 327 patients who had undergone esophagectomy for cancer were included. Multivariate analysis revealed that patients with from three to six involved lymph nodes in the resection specimen on both sides of the diaphragm had a twofold higher chance of dying compared to patients with the same number of involved lymph nodes on one side of the diaphragm. EUS assessment of lymph node metastases relative to the diaphragm in 102 patients showed that nodal involvement on both sides of the diaphragm was associated with worse survival than when nodes on one side or no nodes are involved [HR (95 % CI) 2.38 (1.15-4.90)].
CONCLUSIONS: A combined staging system that incorporates distribution of lymph nodes relative to the diaphragm refines prognostication after esophagectomy as assessed in the resected specimen and pretreatment as assessed by EUS. This improved staging has the potential to have a great impact on clinical decision making as to whether to embark upon potentially curative or palliative treatments.

Entities:  

Mesh:

Year:  2014        PMID: 24101018     DOI: 10.1007/s00268-013-2236-x

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  25 in total

Review 1.  Lymph node metastases and prognosis in oesophageal carcinoma--a systematic review.

Authors:  B Kayani; E Zacharakis; K Ahmed; G B Hanna
Journal:  Eur J Surg Oncol       Date:  2011-09       Impact factor: 4.424

2.  New Japanese classifications and treatment guidelines for gastric cancer: revision concepts and major revised points.

Authors:  Takeshi Sano; Takashi Aiko
Journal:  Gastric Cancer       Date:  2011-06       Impact factor: 7.370

3.  A comparison of the accuracy of echo features during endoscopic ultrasound (EUS) and EUS-guided fine-needle aspiration for diagnosis of malignant lymph node invasion.

Authors:  M S Bhutani; R H Hawes; B J Hoffman
Journal:  Gastrointest Endosc       Date:  1997-06       Impact factor: 9.427

4.  Difference between carcinoma of the lower esophagus and the cardia.

Authors:  Y Tachimori; H Kato; H Watanabe; M Sasako; T Kinoshita; K Maruyama
Journal:  World J Surg       Date:  1996-05       Impact factor: 3.352

5.  Esophageal cancer: the mode of lymphatic tumor cell spread and its prognostic significance.

Authors:  S B Hosch; N H Stoecklein; U Pichlmeier; A Rehders; P Scheunemann; A Niendorf; W T Knoefel; J R Izbicki
Journal:  J Clin Oncol       Date:  2001-04-01       Impact factor: 44.544

6.  Value of endoscopic ultrasonography as a predictor of long-term survival in oesophageal carcinoma.

Authors:  C Mariette; J M Balon; V Maunoury; G Taillier; I Van Seuningen; J P Triboulet
Journal:  Br J Surg       Date:  2003-11       Impact factor: 6.939

7.  Tumors of the esophagogastric junction. Long-term survival in relation to the pattern of lymph node metastasis and a critical analysis of the accuracy or inaccuracy of pTNM classification.

Authors:  W H Steup; P De Leyn; G Deneffe; D Van Raemdonck; W Coosemans; T Lerut
Journal:  J Thorac Cardiovasc Surg       Date:  1996-01       Impact factor: 5.209

8.  Lymphatic drainage routes of the gastric cardia visualized by lymphoscintigraphy.

Authors:  Huib A Cense; Gerrit W Sloof; Joost M Klaase; Jacques J Bergman; Formijn J van Hemert; Paul Fockens; Jan J B van Lanschot
Journal:  J Nucl Med       Date:  2004-02       Impact factor: 10.057

9.  Endoscopic ultrasound predicts outcomes for patients with adenocarcinoma of the gastroesophageal junction.

Authors:  Andrew P Barbour; Nabil P Rizk; Hans Gerdes; Manjit S Bains; Valerie W Rusch; Murray F Brennan; Daniel G Coit
Journal:  J Am Coll Surg       Date:  2007-07-20       Impact factor: 6.113

10.  Chemotherapy followed by surgery versus surgery alone in patients with resectable oesophageal squamous cell carcinoma: long-term results of a randomized controlled trial.

Authors:  Jurjen J Boonstra; Tjebbe C Kok; Bas Pl Wijnhoven; Mark van Heijl; Mark I van Berge Henegouwen; Fiebo Jw Ten Kate; Peter D Siersema; Winand Nm Dinjens; Jan Jb van Lanschot; Hugo W Tilanus; Ate van der Gaast
Journal:  BMC Cancer       Date:  2011-05-19       Impact factor: 4.430

View more
  8 in total

Review 1.  The extent of lymphadenectomy in esophageal resection for cancer should be standardized.

Authors:  Eliza R C Hagens; Mark I van Berge Henegouwen; Miguel A Cuesta; Suzanne S Gisbertz
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

2.  Transhiatal robot-assisted minimally invasive esophagectomy: unclear benefits compared to traditional transhiatal esophagectomy.

Authors:  Toby P Keeney-Bonthrone; Kenneth L Abbott; Caleb Haley; Monita Karmakar; Armani M Hawes; Andrew C Chang; Jules Lin; William R Lynch; Philip W Carrott; Kiran H Lagisetty; Mark B Orringer; Rishindra M Reddy
Journal:  J Robot Surg       Date:  2021-09-28

3.  Does the lymph node yield affect survival in patients with esophageal cancer receiving neoadjuvant therapy plus esophagectomy? A systematic review and updated meta-analysis.

Authors:  Donglai Chen; Yiming Mao; Yuhang Xue; Yonghua Sang; Desen Liu; Yongbing Chen
Journal:  EClinicalMedicine       Date:  2020-07-31

4.  Tumor location is an independent prognostic factor of esophageal adenocarcinoma based on the eighth edition of TNM staging system in Chinese patients.

Authors:  Han-Yu Deng; Xi Zheng; Guha Alai; Gang Li; Jun Luo; Ze-Guo Zhuo; Yi-Dan Lin
Journal:  Ann Transl Med       Date:  2019-08

5.  Endoscopic ultrasound: Elastographic lymph node evaluation.

Authors:  Christoph F Dietrich; Christian Jenssen; Paolo G Arcidiacono; Xin-Wu Cui; Marc Giovannini; Michael Hocke; Julio Iglesias-Garcia; Adrian Saftoiu; Siyu Sun; Liliana Chiorean
Journal:  Endosc Ultrasound       Date:  2015 Jul-Sep       Impact factor: 5.628

Review 6.  Evidence-Based Operative Details in Esophageal Cancer Treatment: Surgical Approach, Lymphadenectomy, Anastomosis.

Authors:  Ralf Metzger; Frank Schütze; Stefan Mönig
Journal:  Viszeralmedizin       Date:  2015-10-14

7.  Effect of lymph node examined count on accurate staging and survival of resected esophageal cancer.

Authors:  Wenjie Xia; Suyao Liu; Qixing Mao; Bing Chen; Weidong Ma; Gaochao Dong; Lin Xu; Feng Jiang
Journal:  Thorac Cancer       Date:  2019-04-07       Impact factor: 3.500

Review 8.  Relevant issues in tumor regression grading of histopathological response to neoadjuvant treatment in adenocarcinomas of the esophagus and gastroesophageal junction.

Authors:  F Klevebro; A Tsekrekos; D Low; L Lundell; M Vieth; S Detlefsen
Journal:  Dis Esophagus       Date:  2020-06-15       Impact factor: 3.429

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.